David Robinson, CEO of Endicott, said: “We look forward to working with the TransAlgae team, who represent great expertise and experience, to rapidly advance the scale-up and commercialization of algae biofuels production as a high-quality, sustainable fuel source.”
TransAlgae’s mission is to develop commercially viable algae strains for a variety of algae biomass growth platforms in order to deliver cost effective transportation fuels as well as other non-energy applications.
For the past year, Endicott has been involved in a flexible feedstock development programme for the production of biodiesel, which includes algae oil-to-biodiesel commercialization. Among its future development plans are technologies that provide a higher degree of freedom for algae producers in algae strain selection and algae oil extraction for the production of biofuels.
Noam Gressel, co-founder and board member of TransAlgae, said: “We believe that genetically modified algae provides the best, large-scale, sustainable solution to the multiple resource limitations the global economy is experiencing, providing high-quality alternatives to fossil fuels, petro-chemicals and protein sources without impacting arable land and water.
“Well designed algal crops can fix carbon dioxide emissions into biological molecules, such as carbohydrates, protein and oil, enabling waste carbon dioxide (CO2) producers to turn a cost into a revenue stream.”
